Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis

Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis

US Patent 7915222 · Granted Mar 29, 2011

Estimated economic value: $39,812,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating dermatomyositis or polymyositis by administering a soluble 2018
Methods for treating scleroderma by administering a soluble CTLA4 molecule2016
Method of preventing the development of rheumatoid arthritis in subjects with un2015
Method of preventing the development of rheumatoid arthritis in subjects with un2015
Method of preventing the development of rheumatoid arthritis in subjects with un2015
Methods for treating Sjogrens syndrome by administering a soluble CTLA4 molecule2014
Methods for treating juvenile rheumatoid arthritis by administering a soluble CT2014
Methods for treating type I diabetes mellitus by administering a soluble CTLA4 m2013
Method for retarding progression to definite rheumatoid arthritis in subjects wi2013
Method for retarding progression to definite rheumatoid arthritis in subjects wi2013
Method for retarding progression to definite rheumatoid arthritis in subjects wi2013
Method for treating an autoimmune disease using a soluble CTLA4 molecule and a D2012